MetaCap

Who Owns Pasithea Therapeutics Stock?

NASDAQ: KTTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.4503+0.0094 (+2.13%)

Market open · Delayed 15 min · as of Oct 9, 1:55 PM ET

Ownership breakdown

Held by institutions
63.23%
Institutional holders
28
  • Institutions 63.2%
  • Insiders 1.1%
  • Public and other 35.7%

Who owns Pasithea Therapeutics stock?

Institutional investors own about 63.2% of Pasithea Therapeutics's shares, spread across 28 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 1.11% of KTTA.

The largest institutional holders are Cable Car Capital, LP (8.98%), Stonepine Capital Management, LLC (6.59%) and Adage Capital Partners GP L.L.C. (6.28%). Together, the top 10 institutions control 47.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their KTTA positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of KTTA

Pasithea Therapeutics top institutional holders
InstitutionShares% HeldChange
Cable Car Capital, LP3.00M8.98%+148.7%
Stonepine Capital Management, LLC2.20M6.59%+164.8%
Adage Capital Partners GP L.L.C.2.10M6.28%0.0%
Jupiter Topco LLC2.10M6.28%+100.0%
Opaleye Management Inc.2.05M6.14%+100.0%
Ameriprise Financial, Inc.1.86M5.58%+38.0%
Squadron Capital Management LLC1.00M2.99%-52.4%
AdvisorShares Investments, LLC937.55K2.81%+177.8%
Vivo Capital, LLC465.47K1.39%-77.8%
Persistent Asset Partners Ltd290.56K0.87%0.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of KTTA

Pasithea Therapeutics top fund holders
FundShares% Held
AdvisorShares Trust-AdvisorShares Psychedelics ETF1.16M3.47%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund126.28K0.38%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund57.82K0.17%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund13.44K0.04%
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund7.97K0.02%

Frequently asked questions

Who is the largest shareholder of Pasithea Therapeutics?

Cable Car Capital, LP is the largest institutional shareholder of KTTA, owning 8.98% of shares outstanding (3.00M shares) as of its latest 13F filing.

What percentage of Pasithea Therapeutics is owned by institutions?

Institutions own about 63.2% of KTTA shares and 63.9% of the public float.

How much of Pasithea Therapeutics do insiders own?

Insiders, such as officers and directors, own about 1.11% of KTTA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related